Skip to main content
Clinical Trials/NCT03612934
NCT03612934CompletedNot Applicable

The Influence of Specialist Palliative Care on the Exacerbation of Negative Symptoms, Life Quality and Performance Status of Patients With Advanced Breast Cancer

Silesian University of Medicine0 sites144 target enrollmentStarted: May 1, 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
144
Primary Endpoint
Variation of performance status of patients before and after SPC

Study Overview

Brief Summary

The aim of this prospective, observational study is the evaluation of the effectiveness of a 14-day Specialist Palliative Care therapy in participants with advanced breast cancer carried out in a stationary palliative care unit in Poland. The length of the entire study will be 36 months.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
33 Years to 91 Years (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
No

Inclusion Criteria

  • the patient's conscious consent for examination and the ability to fill in the form by the patient herself.

Exclusion Criteria

  • patients with cognitive disturbances disabling credible answers in the questionnaire, deceased patients or those discharged from the ward before 14 days of hospitalisation.

Outcomes

Primary Outcomes

Variation of performance status of patients before and after SPC

Time Frame: 14 days

performance status of patients was assessed by ECOG scale (Eastern Cooperative Oncology Group)

Variation of intensification of patients negative symptoms before and after SPC

Time Frame: 14 days

intensification of patients negative symptoms was assessed by Edmonton Symptom Assessment System (esas)

Variation of quality of life of patients before and after SPC

Time Frame: 14 days

quality of life of patients of patients was assessed by quality of life uniscale (QoLU)

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Silesian University of Medicine
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Łukasz Pietrzyński

Principal Investigator

Silesian University of Medicine

Similar Trials

The Impact of SPC on Advanced Breast... | Clinical Trial